Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CRD007 Mannitol Challenge in Asthma
NCT02609334Phase 2Completed
- Sponsor
- RSPR Pharma
- Start
- Mar 2015
- Primary completion
- Jul 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of pemirolast in asthma (3 arms), sponsored by RSPR Pharma. Primary endpoint: Provocative Dose of Mannitol Causing a 15% Fall in FEV1. Started Mar 2015; status: completed.
02
Drugs
pemirolast
03
Conditions
asthma
Beyond the preview
Go deeper on NCT02609334.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02609334.